日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial

阿特珠单抗联合恩扎卢胺对比恩扎卢胺单药治疗转移性去势抵抗性前列腺癌:一项随机3期试验

Powles, Thomas; Yuen, Kobe C; Gillessen, Silke; Kadel, Edward E 3rd; Rathkopf, Dana; Matsubara, Nobuaki; Drake, Charles G; Fizazi, Karim; Piulats, Josep M; Wysocki, Piotr J; Buchschacher, Gary L Jr; Alekseev, Boris; Mellado, Begoña; Karaszewska, Bogusława; Doss, Jennifer F; Rasuo, Grozdana; Datye, Asim; Mariathasan, Sanjeev; Williams, Patrick; Sweeney, Christopher J

Drug-Drug Interaction Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Ipatasertib in Combination with Darolutamide in Patients with Advanced Prostate Cancer

药物相互作用研究:评估伊帕他替尼联合达罗鲁胺治疗晚期前列腺癌患者的药代动力学、安全性和耐受性

Sutaria, Dhruvitkumar S; Rasuo, Grozdana; Harris, Adam; Johnson, Ryan; Miles, Dale; Gallo, Jorge Daniel; Sane, Rucha

Platelet-Released Growth Factors Modulate the Secretion of Cytokines in Synoviocytes under Inflammatory Joint Disease.

血小板释放的生长因子调节炎症性关节疾病下滑膜细胞中细胞因子的分泌

Tohidnezhad Mersedeh, Bayer Andreas, Rasuo Biljana, Hock Jennifer Vanessa Phi, Kweider Nisreen, Fragoulis Athanassios, Sönmez Tolga Taha, Jahr Holger, Pufe Thomas, Lippross Sebastian